Skip to main content
SpringerLink
Log in

Surgical Treatment of Intrahepatic Cholangiocarcinoma

  • Reference work entry
  • First Online:
Hepato-Pancreato-Biliary Malignancies

  • 666 Accesses

Abstract

The second most common primary liver cancer is intrahepatic cholangiocarcinoma (iCCA). The only potentially curative treatment for iCCA is surgical resection, although the majority of patients will present with unresectable, locally advanced, or metastatic disease at diagnosis. The focus of surgical management is margin-negative resection with preservation of an adequate liver remnant volume and function. Extensive liver resection including adjacent involved structures such as the extrahepatic bile duct, major vessels, and diaphragm may be required to achieve negative resection margins. For patients with high-risk features, the routine use of diagnostic laparoscopy with the selective use of laparoscopic ultrasonography is recommended to identify occult metastatic disease. Among the prognostic factors such as lymph node (LN) involvement, tumor size, multicentricity, margin status, tumor differentiation, and vascular invasion, LN metastasis is the most important prognostic factor for patients undergoing curative-intent resection. Regional lymphadenectomy is recommended at the time of hepatectomy due to the high incidence of LN metastasis and its prognostic relevance. Even in patients who undergo R0 resection, the recurrence rates are high and the long-term survival remains poor. Despite the poor outcomes of liver transplantation for iCCA, liver transplantation may be a therapeutic option for selected patients with early-stage iCCA, especially for patients with an adequate response to neoadjuvant therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 329.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lubezky N, Facciuto M, Harimoto N, et al. Surgical treatment of intrahepatic cholangiocarcinoma in the USA. J Hepatobiliary Pancreat Sci. 2015;22(2):124–30.

    Article  Google Scholar 

  2. Rahnemai-Azar AA, Weisbrod AB, Dillhoff M, et al. Intrahepatic cholangiocarcinoma: current management and emerging therapies. Expert Rev Gastroenterol Hepatol. 2017;11(5):439–49.

    Article  CAS  Google Scholar 

  3. Shaib YH, Davila JA, McGlynn K, et al. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol. 2004;40(3):472–7.

    Article  Google Scholar 

  4. Squires MH, Cloyd JM, Dillhoff M, et al. Challenges of surgical management of intrahepatic cholangiocarcinoma. Expert Rev Gastroenterol Hepatol. 2018;12(7):671–81.

    Article  CAS  Google Scholar 

  5. Weber SM, Ribero D, O’Reilly EM, et al. Intrahepatic cholangiocarcinoma: expert consensus statement. HPB. 2015;17(8):669–80.

    Article  Google Scholar 

  6. Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60(6):1268–89.

    Article  Google Scholar 

  7. Endo I, Gonen M, Yopp AC, et al. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg. 2008;248(1):84–96.

    Article  Google Scholar 

  8. Machairas N, Lang H, Jayant K, et al. Intrahepatic cholangiocarcinoma: limitations for resectability, current surgical concepts and future perspectives. Eur J Surg Oncol. 2020;46(5):740–6 https://doi.org/10.1016/j.ejso.2020.01.028.

  9. Wang K, Zhang H, Xia Y, et al. Surgical options for intrahepatic cholangiocarcinoma. Hepatobiliary Surg Nutr. 2017;6(2):79–90.

    Article  Google Scholar 

  10. Buettner S, van Vugt JL, IJermans JN, et al. Intrahepatic cholangiocarcinoma: current perspectives. Onco Targets Ther. 2017;20:1131–42.

    Article  Google Scholar 

  11. Waisberg DR, Pinheiro RS, Nacif LS, et al. Resection for intrahepatic cholangiocellular cancer: new advances. Transl Gastroenterol Hepatol. 2018;3:60.

    Article  Google Scholar 

  12. Nagino M, Kamiya J, Nishio H, et al. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer. Surgical outcome and long-term follow-up. Ann Surg. 2006;243:364–72.

    Article  Google Scholar 

  13. Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990;107:521–7.

    CAS  Google Scholar 

  14. Chaudhary RJ, Higuchi R, Nagino M, et al. Survey of preoperative management protocol for perihilar cholangiocarcinoma at 10 Japanese high-volume centers with a combined experience of 2,788 cases. J Hepatobiliary Pancreat Sci. 2019;26:490–502.

    Article  Google Scholar 

  15. Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg. 2001;88:165–75.

    Article  CAS  Google Scholar 

  16. Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg. 2012;255:405–14.

    Article  Google Scholar 

  17. Bednarsch J, Czigany Z, Lurje I, et al. The role of ALPPS in intrahepatic cholangiocarcinoma. Langenbeck’s Arch Surg. 2019;404(7):885–94.

    Article  Google Scholar 

  18. Schadde E, Raptis DA, Schnitzbauer AA, et al. Prediction of mortality after ALPPS stage-1: an analysis of 320 patients from the international ALPPS registry. Ann Surg. 2015;262:780–5. Discussion 785–6

    Article  Google Scholar 

  19. D’Angelica M, Fong Y, Weber S, et al. The role of staging laparoscopy in hepatobiliary malignancy: prospective analysis of 401 cases. Ann Surg Oncol. 2003;10:183–9.

    Article  Google Scholar 

  20. Goere D, Wagholikar GD, Pessaux P, et al. Utility of staging laparoscopy in subsets of biliary cancers: laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma. Surg Endosc. 2006;20:721–5.

    Article  CAS  Google Scholar 

  21. de Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol. 2011;29:3140–5.

    Article  Google Scholar 

  22. Altman AM, Kizy S, Marmor S, et al. Current survival and treatment trends for surgically resected intrahepatic cholangiocarcinoma in the United States. J Gastrointest Oncol. 2018;9(5):942–52.

    Article  Google Scholar 

  23. Amin MB, Edge S, Greene F, et al. American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging manual. 8th ed. Chicago: Springer; 2017.

    Google Scholar 

  24. Bagante F, Spolverato G, Merath K, et al. Intrahepatic cholangiocarcinoma tumor burden: a classification and regression tree model to define prognostic groups after resection. Surgery. 2019;166(6):983–90.

    Article  Google Scholar 

  25. Farges O, Fuks D, Boleslawski E, et al. Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group. Ann Surg. 2011;254(5):824–9. Discussion 830

    Article  Google Scholar 

  26. Spolverato G, Yakoob MY, Kim Y, et al. The impact of surgical margin status on long-term outcome after resection for intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2015;22(12):4020–8.

    Article  Google Scholar 

  27. Zhang XF, Beal EW, Bagante F, et al. Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent. Br J Surg. 2018;105:848–56.

    Article  Google Scholar 

  28. Buell JF, Cherqui D, Geller DA, et al. The international position on laparoscopic liver surgery: the Louisville statement, 2008. Ann Surg. 2009;250:825–30.

    Article  Google Scholar 

  29. Wakabayashi G, Cherqui D, Geller DA, et al. Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. Ann Surg. 2015;261:619–29.

    Google Scholar 

  30. Kinoshita M, Kanazawa A, Takemura S, et al. Indications for laparoscopic liver resection of mass forming intrahepatic cholangiocarcinoma. Asian J Endosc Surg. 2019:1–3. https://doi.org/10.1111/ases.12703.

  31. Lee W, Park JH, Kim JY, et al. Comparison of perioperative and oncologic outcomes between open and laparoscopic liver resection for intrahepatic cholangiocarcinoma. Surg Endosc. 2016;30:4835–40.

    Article  Google Scholar 

  32. Ratti F, Cipriani F, Ariotti R, et al. Safety and feasibility of laparoscopic liver resection with associated lymphadenectomy for intrahepatic cholangiocarcinoma: a propensity score-based case-matched analysis from a single institution. Surg Endosc. 2016;30:1999–2010.

    Article  Google Scholar 

  33. Uy BJ, Han HS, Yoon YS, et al. Laparoscopic liver resection for intrahepatic cholangiocarcinoma. J Laparoendosc Adv Surg Tech A. 2015;25:272–7.

    Article  Google Scholar 

  34. Wei F, Lu C, Cai L, et al. Can laparoscopic liver resection provide a favorable option for patients with large or multiple intrahepatic cholangiocarcinomas? Surg Endosc. 2017;31:3646–55.

    Article  Google Scholar 

  35. Abu Hilal M, Badran A, Di Fabio F, et al. Pure laparoscopic en bloc left hemihepatectomy and caudate lobe resection in patients with intrahepatic cholangiocarcinoma. J Laparoendosc Adv Surg Tech A. 2011;21:845–9.

    Article  Google Scholar 

  36. Ratti F, Cipriani F, Ariotti R, et al. Laparoscopic major hepatectomies: current trends and indications. A comparison with the open technique. Updat Surg. 2015;67:157–67.

    Article  Google Scholar 

  37. Zhu Y, Song J, Xu X, et al. Safety and feasibility of laparoscopic liver resection for patients with large or multiple intrahepatic cholangiocarcinomas: a propensity score based case-matched analysis from a single institute. Medicine. 2019;98(49):e18307.

    Article  Google Scholar 

  38. Zamora-Valdes D, Heimbach JK. Liver transplant for cholangiocarcinoma. Gastroenterol Clin N Am. 2018;47:267–80.

    Article  Google Scholar 

  39. Sapisochin G, Facciuto M, Rubbia-Brandt L, et al. Liver transplantation for “very early” intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment. Hepatology. 2016;64(4):1178–88.

    Article  CAS  Google Scholar 

  40. Lunsford KE, Javle M, Heyne K, et al. Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case series. Lancet Gastroenterol Hepatol. 2018;3:337–48.

    Article  Google Scholar 

  41. Moris D, Kostakis ID, Machairas N, et al. Comparison between liver transplantation and resection for hilar cholangiocarcinoma: a systematic review and meta-analysis. PLoS One. 2019;14:e0220527.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hepatobiliary surgery and Liver transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea

    Ki-Hun Kim

  2. Department of Surgery, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea

    Jeong-Ik Park

Authors
  1. Ki-Hun Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeong-Ik Park
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ki-Hun Kim .

Editor information

Editors and Affiliations

  1. Medical Director, Capital Health Cancer Center, Director, CH Pancreas Center of Excellence, Director, CH Liver Center of Excellence, Pennington, NJ, USA

    Cataldo Doria

  2. Director of Interventional Gastroenterology, Capital Health Medical Center, Pennington, NJ, USA

    Jason N. Rogart

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Kim, KH., Park, JI. (2022). Surgical Treatment of Intrahepatic Cholangiocarcinoma. In: Doria, C., Rogart, J.N. (eds) Hepato-Pancreato-Biliary Malignancies. Springer, Cham. https://doi.org/10.1007/978-3-030-41683-6_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-41683-6_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-41682-9

  • Online ISBN: 978-3-030-41683-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation